Once-daily administration of 2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. Results of a Phase I trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples